Free Trial
NASDAQ:COO

Cooper Companies (COO) Stock Price, News & Analysis

$87.30
-0.32 (-0.37%)
(As of 06/28/2024 08:56 PM ET)
Today's Range
$86.70
$88.67
50-Day Range
$87.30
$97.90
52-Week Range
$75.93
$104.07
Volume
1.97 million shs
Average Volume
1.11 million shs
Market Capitalization
$17.38 billion
P/E Ratio
51.28
Dividend Yield
N/A
Price Target
$111.42

Cooper Companies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.73 Rating Score
Upside/​Downside
27.6% Upside
$111.42 Price Target
Short Interest
Healthy
1.49% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.73mentions of Cooper Companies in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.64%
From $3.57 to $3.95 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.50 out of 5 stars

Medical Sector

381st out of 916 stocks

Ophthalmic Goods Industry

3rd out of 8 stocks

COO stock logo

About Cooper Companies Stock (NASDAQ:COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO Stock Price History

COO Stock News Headlines

Republican presidential candidate former President Donald Trump walks to the podium at a campaign e…
Trump is proposing to make tips tax-free. What would that mean for workers?
Former President Donald Trump’s proposal to exclude tips from federal taxes is getting strong reviews from some Republican lawmakers
Dan McLean, shown Wednesday, March 6, 2024, points to where Summit Carbon Solutions' proposed carbo…
Biofuel groups envision ethanol-powered jets. But fueling the effort has not been easy
Farming and biofuels organizations are hopeful that ethanol could be used to power passenger jets, but making that dream a reality hasn’t been easy
Where AI is REALLY Going Next
Buying Nvidia was a good idea – twenty years ago when I first recommended it (for up to 37,000% gains). But chipmakers are the FIRST GENERATION of AI. And just like the dot-com era… That’s NOT where the big money will be made.
Entertainer Snoop Dogg walks on the field before an NFL football game between the Tampa Bay Buccane…
Inside NBC's Olympics bet on pop culture in Paris, with help from Snoop Dogg and Cardi B
NBC has partnered with several entertainers and non-Olympic athletes like Megan Thee Stallion, Dolly Parton and Peyton Manning to promote the Paris Games this summer
10 Best Stock Picks of Billionaire Leon Cooperman in 2024
Where AI is REALLY Going Next
Buying Nvidia was a good idea – twenty years ago when I first recommended it (for up to 37,000% gains). But chipmakers are the FIRST GENERATION of AI. And just like the dot-com era… That’s NOT where the big money will be made.
Assessing Cooper Companies: Insights From 7 Financial Analysts
Cooper’s Hawk to close in Fort Lauderdale
See More Headlines

Company Calendar

Last Earnings
5/30/2024
Today
7/01/2024
Next Earnings (Estimated)
9/04/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:COO
CUSIP
21664840
Employees
15,000
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$111.42
High Stock Price Target
$125.00
Low Stock Price Target
$88.75
Potential Upside/Downside
+27.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Net Income
$294.20 million
Pretax Margin
12.73%

Debt

Sales & Book Value

Annual Sales
$3.59 billion
Cash Flow
$5.08 per share
Book Value
$39.19 per share

Miscellaneous

Free Float
195,138,000
Market Cap
$17.38 billion
Optionable
Optionable
Beta
1.02

Social Links


COO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" COO shares.
View COO analyst ratings
or view top-rated stocks.

What is Cooper Companies' stock price target for 2024?

11 equities research analysts have issued 1-year target prices for Cooper Companies' stock. Their COO share price targets range from $88.75 to $125.00. On average, they predict the company's share price to reach $111.42 in the next twelve months. This suggests a possible upside of 27.6% from the stock's current price.
View analysts price targets for COO
or view top-rated stocks among Wall Street analysts.

How have COO shares performed in 2024?

Cooper Companies' stock was trading at $94.61 at the start of the year. Since then, COO stock has decreased by 7.7% and is now trading at $87.30.
View the best growth stocks for 2024 here
.

Are investors shorting Cooper Companies?

Cooper Companies saw a increase in short interest in June. As of June 15th, there was short interest totaling 2,970,000 shares, an increase of 14.7% from the May 31st total of 2,590,000 shares. Based on an average trading volume of 1,070,000 shares, the short-interest ratio is currently 2.8 days.
View Cooper Companies' Short Interest
.

When is Cooper Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 4th 2024.
View our COO earnings forecast
.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) posted its earnings results on Thursday, May, 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.02. The medical device company earned $942.60 million during the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a net margin of 9.11% and a trailing twelve-month return on equity of 8.87%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.77 earnings per share.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a quarterly dividend on Wednesday, July 12th. Shareholders of record on Thursday, July 27th will be given a dividend of $0.0075 per share on Friday, August 11th. This represents a $0.03 dividend on an annualized basis and a dividend yield of 0.03%. The ex-dividend date is Wednesday, July 26th.
Read our dividend analysis for COO
.

When did Cooper Companies' stock split?

Cooper Companies shares split on the morning of Tuesday, February 20th 2024. The 4-1 split was announced on Tuesday, February 20th 2024. The newly minted shares were payable to shareholders after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY 2024 earnings guidance on Thursday, May, 30th. The company provided earnings per share guidance of 3.540-3.600 for the period, compared to the consensus earnings per share estimate of 3.540. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Cooper Companies have any subsidiaries?
The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More
This page (NASDAQ:COO) was last updated on 7/1/2024 by MarketBeat.com Staff

From Our Partners